Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that a more comprehensive and precise approach is needed for diagnosing PCOS to address its broader health risks.

Women with PCOS often have more belly fat and higher insulin levels, but belly fat isn't the only cause of their insulin resistance.

Higher levels of unbound testosterone are linked to increased insulin resistance, especially in women with polycystic ovary syndrome.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

Myo-inositol may be more effective than metformin for inducing ovulation in women with PCOS.

Adults with polycystic ovary syndrome are much more likely to have obstructive sleep apnea.

Women with PCOS are more likely to have sleep apnea, mainly if they are obese.

High androgen levels in Chinese women with PCOS are linked to a higher risk of diabetes and obesity.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

Obese women with PCOS are more likely to have fatty liver disease.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Researchers found potential urine markers for polycystic ovary syndrome, including testosterone-glucuronide and 11α-hydroxyprogesterone, which may help diagnose the condition.

Most patients improved with oral contraceptives, but some needed additional treatment.

A combined drug and laser treatment improved hirsutism in a PCOS patient, also enhancing her heart health and requiring regular liver and kidney checks.

The research suggests that the ZP4 gene is linked to egg development in women with PCOS but requires more study to understand its role in infertility.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Type 2 diabetes does not change how metformin works in obese pregnant women, so dosage adjustments are not needed.

Different levels of anti-Müllerian hormone can help diagnose polycystic ovary syndrome in women of different ages.

Lower vaspin levels in the blood may indicate a better response to fertility treatment in women with PCOS.

Metformin helps improve symptoms and reproductive outcomes in people with polycystic ovary syndrome.

Women with PCOS have more insulin resistance and are more likely to have heart-related health issues, with insulin resistance being a bigger factor than β-cell problems.

Hair loss is linked to insulin resistance in women, regardless of hormone levels.

Indian women with PCOS may need different ultrasound criteria for diagnosis than current standards.

Rosuvastatin improves lipid levels, reduces inflammation, but worsens insulin sensitivity in men with early-onset hair loss.